Anhedonia remains one of the most disabling and difficult-to-treat features of major depressive disorder. This session reviews the evolving understanding of reward system dysfunction, explores practical methods for identifying and assessing anhedonia, and evaluates emerging therapies designed to improve meaningful recovery and patient-centered outcomes.<br><br>Supported by an educational grant from Axsome Therapeutics Inc.